tiprankstipranks
Advertisement
Advertisement

CellaVision Expands Digital Hematology Platform With Bone Marrow Aspirate Launch in EMEA

Story Highlights
  • CellaVision launches CE-marked AI-assisted Bone Marrow Aspirate Application in EMEA, digitalizing complex cancer diagnostics.
  • Through Sysmex partnership and major hematology symposium debut, CellaVision strengthens its position in advanced lab diagnostics.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CellaVision Expands Digital Hematology Platform With Bone Marrow Aspirate Launch in EMEA

Claim 30% Off TipRanks

CellaVision AB ( (SE:CEVI) ) has provided an update.

CellaVision has launched its CellaVision Bone Marrow Aspirate Application across the EMEA region, expanding its digital cell morphology platform into bone marrow aspirate analysis, a key tool in diagnosing and monitoring blood cancers and other serious blood diseases. The CE-marked, AI-assisted application aims to automate, standardize, and simplify bone marrow morphology, providing laboratories with more consistent and traceable results while addressing the traditionally manual and expertise-dependent nature of these examinations.

The company will distribute the new application in collaboration with Sysmex Corporation, leveraging established relationships with hospital and reference laboratories to accelerate adoption in the EMEA market. CellaVision plans to introduce the solution to the hematology community at the International Symposium on Technological Innovations in Laboratory Hematology in April 2026, a move that underscores its ambition to strengthen its position in advanced laboratory diagnostics and support long-term growth targets.

The most recent analyst rating on (SE:CEVI) stock is a Buy with a SEK184.00 price target. To see the full list of analyst forecasts on CellaVision AB stock, see the SE:CEVI Stock Forecast page.

More about CellaVision AB

CellaVision AB is a global medical technology company specializing in automated systems for routine analysis of blood and other body fluids used in healthcare diagnostics. Its AI-driven image analysis and automated microscopy solutions replace manual laboratory work, improving workflow efficiency and diagnostic consistency across more than 40 countries, with sales mainly via global partners and local support organizations.

Average Trading Volume: 36,451

Technical Sentiment Signal: Sell

Current Market Cap: SEK3.62B

For an in-depth examination of CEVI stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1